Overeating is linked to a malfunction in the hypothalamic arcuate nucleus, which is where neuropeptide Y (NPY), agouti-related peptide (AgRP), proopiomelanocortin (POMC), and leptin interact to regulate food intake and body weight
When combined with your provider's evaluation of kidney function, thyroid status, pancreatic health, and metabolic markers, genetic predisposition data may enhance the rationale for your specific treatment choice, formulation (oral vs
Individual results may vary based on skin type and goals
GLP-1s were initially used to treat diabetes, and the proposal would not affect anyone taking them for that purpose, only prescriptions for weight loss
There is evidence that titrating GLP-1 dosage and switching between GLP-1 medications can occur in clinical practice due to factors such as lack of desired impact, patient preference, insurance coverage and side effects
Seek medical attention if you have concerns about your health